![]() |
市场调查报告书
商品编码
2021530
种子技术创新市场预测至2034年—按产品类型、性状、作物类型、应用、最终用户和地区分類的全球分析Seed Technology Innovations Market Forecasts to 2034 - Global Analysis By Product Type, Trait, Crop Type, Application, End User and By Geography |
||||||
根据 Stratistics MRC 的数据,2026 年全球种子技术创新市场价值将达到 684 亿美元,预计在预测期内将以 10.1% 的复合年增长率增长,到 2034 年达到 1,486 亿美元。
种子技术创新是指先进的植物育种调查方法、基因修饰平台、分子标记系统和精准编辑技术,例如基于CRISPR的基因组编辑、标记辅助选择、基因改造作物开发和计算基因组学。这些技术应用于培育具有更高产量、更强非生物胁迫耐受性、更强抗病性、更高营养价值和更高投入利用效率的商业性优良作物品种,从而显着提高不同种植系统和地区农民的农业生产力和永续性。
投资粮食安全的迫切性
气候变迁导致作物产量波动、人口营养需求不断增长以及耕地资源有限,加剧了全球粮食安全挑战,促使公共和私营部门迫切投资于先进种子技术研发,以维持全球作物生产力成长趋势。政府对农业研究的资助以及对国际粮食安全项目的投资,使得小麦、水稻、玉米和大豆等主要粮食作物对耐旱、抗病和高产种子品种的需求持续图。
基因改造作物面临的监管障碍
欧盟市场对基改作物严格的核准要求,以及许多开发中国家监管的不确定性,导致基改作物的审批流程耗时多年,监管投入庞大,从而限制了基改种子技术的地域覆盖范围,并将商业性利益集中在已建立基改作物法规结构的市场。此外,儘管基因改造作物已被证明具有农业效益,但欧洲主要消费市场消费者对基因改造生物的怀疑态度也限制了商业化基因改造种子的普及。
CRISPR种子创新管道
基于CRISPR技术的精准育种创新流程正在关键市场创造巨大的商业机会,包括美国、日本以及日益重要的巴西。在这些市场,基因编辑作物比基因改造品种享有更优惠的监管待遇。这使得精准编辑的作物性状(例如抗病性、耐旱性和更高的营养价值)能够更快地商业性,从而在允许非基因改造基因组的法规结构内,为农民带来他们所重视的性能优势。
自留种子做法的衰落
农民保存种子的做法以及日益壮大的开放原始码植物育种运动对商业性种子技术公司构成了收入威胁。捍卫农民种子权和获取非专有品种的运动正在产生市场和监管压力,这可能会限制先进种子技术创新智慧财产权保护的期限和范围。因此,私部门在某些作物改良优先领域的育种计画的商业性奖励报酬率将会降低。
新冠疫情导致的种子供应链中断,使得多个农业市场在播种季节出现种子短缺,暴露了农民对集中式商业种子供应链的依赖,并加速了对种子系统韧性的投资。疫情期间,人们对粮食安全的日益关注,促使政府和投资部门更加重视透过先进种子技术提高农业生产力。后疫情时代,对农业永续性的投资动能持续强劲,为私人育种计画和公共农业研究机构的种子技术创新提供了资金支持。
在预测期内,基因编辑种子片段预计将是规模最大的。
预计在预测期内,基因编辑种子领域将占据最大的市场份额。这主要归功于CRISPR编辑作物品种商业化的快速推进,这些品种在主要市场享有有利的监管环境,使其商业化速度比基因改造品种更快。此外,具有增产和抗逆性等优势的高性能、精准编辑品种正受到农民的广泛青睐,其销售价格也因此水涨船高,而更高的农业效益也为其带来了丰厚的回报。
预计在预测期内,抗除草剂作物细分市场将呈现最高的复合年增长率。
在预测期内,除草剂耐受性种子市场预计将呈现最高的成长率,这主要得益于市场对与新型选择性除草剂化学成分相容的新一代除草剂耐受性种子性状的需求不断增长。这一增长的驱动力在于,随着杂草控制压力日益成为北美、南美和亚太地区主要农作物市场作物生产力和种子技术选择决策的主要驱动因素,农民越来越多地采用包含高耐除草剂品种的杂草管理系统。
在预测期内,北美预计将占据最大的市场份额。这是因为美国是全球最大的商业种子市场,其玉米、大豆、棉花和菜籽生产系统广泛采用先进的转基因和分子育种技术,而且像科迪华农业科技、拜耳作物科学和先正达这样的领先种子技术创新企业也贡献了全球大部分先进种子技术研发和商业收入。
在预测期内,亚太地区预计将呈现最高的复合年增长率。这主要归功于印度、中国、印尼和越南实施了雄心勃勃的作物生产力提升计划,这些计划融合了先进的杂交育种和分子育种技术,应用于水稻、小麦、蔬菜和棉花等作物;同时,这些国家还提高了国内种子技术研发能力,并透过扩大农村分销网络,增加了农民获得改良商业种子品种的途径。
According to Stratistics MRC, the Global Seed Technology Innovations Market is accounted for $68.4 billion in 2026 and is expected to reach $148.6 billion by 2034 growing at a CAGR of 10.1% during the forecast period. Seed technology innovations refer to advanced plant breeding methodologies, genetic enhancement platforms, molecular marker systems, and precision editing technologies including CRISPR-based genomic editing, marker-assisted selection, transgenic trait development, and computational genomics applied to develop commercially superior crop seed varieties with enhanced yield performance, abiotic stress tolerance, disease resistance, nutritional quality, and input-use efficiency that deliver measurable agricultural productivity and sustainability improvements to farmers across diverse cropping systems and geographies.
Food Security Investment Urgency
Global food security challenges intensified by climate-driven crop yield volatility, growing population nutritional demands, and arable land constraints are driving urgent public and private investment in advanced seed technology development to maintain global crop productivity trajectory. Government agricultural research funding commitments and international food security program investments are generating sustained demand for drought-tolerant, disease-resistant, and yield-enhanced seed varieties across major staple crop categories including wheat, rice, maize, and soybean.
GM Crop Regulatory Barriers
Stringent genetically modified crop regulatory approval requirements across European Union markets and regulatory uncertainty in multiple developing economy jurisdictions create multi-year commercialization timelines and substantial regulatory investment requirements that limit genetic seed technology adoption geography and concentrate commercial benefit in markets with established GM crop regulatory frameworks. Consumer skepticism toward genetically modified organisms in key European consumer markets restricts commercial GM seed deployment despite demonstrated agronomic benefits.
CRISPR Seed Innovation Pipeline
CRISPR-based precision breeding innovation pipeline is creating a substantial commercial opportunity as the more favorable regulatory treatment of genomic-edited crops compared to transgenic GM varieties in key markets including the United States, Japan, and increasingly Brazil enables faster commercialization timelines for precision-edited crop traits including disease resistance, drought tolerance, and nutritional quality enhancement that deliver farmer-valued performance benefits within regulatory frameworks accommodating non-transgenic genome modifications.
Seed Saving Practice Erosion
Farmer seed saving practices and growing open-source plant breeding movements represent commercial revenue threats to commercial seed technology companies as advocacy for farmer seed rights and alternative non-proprietary variety access creates market and regulatory pressure that may limit intellectual property protection duration and scope for advanced seed technology innovations, reducing commercial return-on-investment incentives for private sector breeding program investment in specific crop improvement priority areas.
COVID-19 seed supply chain disruptions generating planting season input shortages in multiple agricultural markets exposed farmer dependence on concentrated commercial seed supply chains and accelerated seed system resilience investment. Pandemic-era food security attention elevated political and investment priority for agricultural productivity enhancement through advanced seed technology. Post-pandemic agricultural sustainability investment momentum continues supporting seed technology innovation funding across both private breeding programs and public agricultural research institutions.
The genomic-edited seeds segment is expected to be the largest during the forecast period
The genomic-edited seeds segment is expected to account for the largest market share during the forecast period, due to rapidly expanding commercial pipeline of CRISPR-edited crop varieties receiving favorable regulatory treatment in major markets enabling faster commercialization compared to transgenic alternatives, combined with strong farmer adoption of high-performance precision-edited varieties delivering demonstrable yield and stress tolerance benefits that command premium seed prices justified by improved agronomic outcomes.
The herbicide tolerance segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the herbicide tolerance segment is predicted to witness the highest growth rate, driven by expanding demand for next-generation herbicide-tolerant seed traits compatible with newer selective herbicide chemistries as farmer adoption of weed management systems incorporating advanced herbicide-tolerant varieties continues growing across major row crop markets in North America, South America, and Asia Pacific where weed pressure management represents a primary driver of crop productivity and seed technology selection decisions.
During the forecast period, the North America region is expected to hold the largest market share, due to the United States representing the world's largest commercial seed market with extensive adoption of advanced GM and molecular breeding technologies across corn, soybean, cotton, and canola production systems, combined with leading seed technology innovators including Corteva Agriscience, Bayer Crop Science, and Syngenta generating the majority of global advanced seed technology research and commercial revenue.
Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, due to India, China, Indonesia, and Vietnam implementing ambitious crop productivity improvement programs incorporating advanced hybrid and molecular breeding seed technologies for rice, wheat, vegetables, and cotton crops, combined with growing domestic seed technology development capability and expanding farmer access to improved commercial seed varieties through expanding rural distribution networks.
Key players in the market
Some of the key players in Seed Technology Innovations Market include Bayer AG, Corteva Agriscience, Syngenta AG, BASF SE, Limagrain Group, KWS SAAT SE & Co. KGaA, Sakata Seed Corporation, DLF Seeds A/S, Advanta Seeds, Rijk Zwaan, Enza Zaden, Nuziveedu Seeds Ltd., UPL Limited, Mahindra Agri Solutions, Takii & Co., Ltd., Vilmorin & Cie, and FMC Corporation.
In March 2026, Corteva Agriscience launched a new CRISPR-edited drought-tolerant corn hybrid delivering significant yield advantages under water-limited growing conditions compared to conventional hybrid varieties in key U.S. Corn Belt markets.
In February 2026, Syngenta AG introduced a new generation of marker-assisted soybean varieties with combined soybean cyst nematode resistance and improved yield potential targeting Midwest U.S. and Brazilian production systems.
In January 2026, Bayer AG announced commercial launch of precision-edited wheat varieties with enhanced disease resistance to Fusarium head blight for European and North American markets, pending final regulatory approvals.
Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) Regions are also represented in the same manner as above.